MicroRNA 4782 (miR-4782)

MicroRNA 4782 (miR-4782, hsa-mir-4782) is a non-coding RNA molecule of the microRNA family. Like other microRNAs, it acts as a post-transcriptional regulator of gene expression by binding to complementary sequences in target mRNAs, resulting in translational repression or mRNA degradation[1][2][5]. A specific mature form, miR-4782-3p, has been identified as having tumor-suppressive properties in epithelial ovarian cancer, suggesting a role in cancer biology[6]. However, there is limited information in standard reference databases or major reviews about MIR4782, and it does not appear to be a classical druggable therapeutic target such as a receptor or enzyme. The available data point to its involvement in gene regulation and possibly cancer suppression, but structural or drug-targeting roles are not established. ### Key points and outlook: - MicroRNA 4782 is best classified as a regulatory RNA, not a conventional therapeutic target like protein receptors or enzymes. - There is some functional evidence for its role as a tumor suppressor in specific cancers, but data remain sparse[6]. - No drugs are currently reported to target MIR4782 or its mature/active forms. - This target is likely incorrect as a classical "therapeutic target" (receptor/enzyme/transporter), and information in databases is incomplete/lacking. If you require information on more broadly studied microRNAs or classical therapeutic targets, those would yield more comprehensive and structured data.

Other names

hsa-mir-4782miR-4782-3p